ABO & Rh(D) Testing

Tailor your ABO & Rh testing to your lab with complete freedom and reliability.

FDA / United States: Grifols offers standard and reliable ABO/Rh testing using gel technology and using conventional techniques. Additionally, genotyping is available, for difficult cases where there is an ABO discrepancy or where Rh status is in question.

CE / Europe: Grifols offers standard and reliable ABO/Rh testing using gel technology and conventional techniques. Additionally, genotyping is available to detect clinically relevant RhD variants and confirm RhD negative results.

Gel card technology

Keep testing organized and efficient for every type of lab

FDA / United States: DG Gel gives you a seamless transition to greater complexity and a higher volume of testing. With an original 8-well format, DG Gel cards give you the flexibility to test any number of ABO & Rh combinations on a single card. Whether you test manually, semi-automated, or fully automated, DG Gel cards keep your test flow organized and efficient.

CE / Europe: DG Gel gives you a seamless transition to greater complexity and a higher volume of testing. With an original 8-well format, DG Gel cards give you the flexibility to test any number of ABO & Rh combinations on a single card, including always the control well together with RhD determination. Whether you test manually, semi-automated, or fully automated, DG Gel cards keep your test flow organized and efficient.

Conventional techniques

Conventional reagents that are a proven and reliable solution for every type of lab

FDA / United States: Reagent Red Blood Cells 3% and antisera that are a proven and reliable solution for every type of lab

FDA / United States: Whether you are utilizing conventional tube reagents for most of your testing or for resolving problematic cases, it is important to have a wide range of reagent red blood cells and antisera to meet your needs.

FDA / United States: Simplifying antibody screening procedures for conventional serology is easy with our extensive range of reagents.

CE / Europe: Test any number of ABO & Rh combinations with antisera that simplifies procedures. ABO and Rh antisera do not require incubation. They offer a drop, spin, and read process for rapid turnaround time.

Molecular technology (CE / Europe)

Go beyond serological testing for your most complex cases (CE / Europe)

CE / Europe: Enhance your ability to confirm the Rh(D) negative donors, rationalize the use of RhIG injections for pregnant women as well as the use of Rh(D) neg blood units for patients with BLOODchip ID RHD XT. Predict the RhD phenotype that cannot be resolved by serology and benefit from knowing the patient's or donor's genotype with a user-friendly streamlined workflow ready in just 4 hours and that only requires 30 minutes of hands-on time.